Europe — EMA

Pantoprazol Ratiopharm (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazol Ratiopharm, is a proton pump inhibitor presented as a tablet for oral use.

Pantoprazole Sodium Sesquihydrate

Request sourcing

Pack/s

What is Pantoprazole Sodium Sesquihydrate?

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazol Ratiopharm, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children.

GNH USA supplies Pantoprazol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Pantoprazole Sodium Sesquihydrate used for?

Pantoprazol Ratiopharm is a proton pump inhibitor that addresses conditions linked to excess gastric acid secretion. - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the oesophageal lining. - Erosive esophagitis: accelerates healing of ulcerated oesophageal tissue. - Peptic ulcer disease (PUD) – gastric and the

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →